BMCM
MEDP icon

Burns Matteson Capital Management’s Medpace MEDP Stock Holding History

Burns Matteson Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-562
Closed -$270K – 227
2026
Q1 		$270K Sell
562
-8
-1% -$4.1K 0.1% 171
2025
Q4 		$320K Buy
+570
New +$324K 0.11% 150

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Burns Matteson Capital Management's MEDP Position: Q2 2026 in Review

Burns Matteson Capital Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 562 shares — an estimated $270K sold.

Burns Matteson Capital Management first reported a position in MEDP in Q4 2025 and held it in 2 quarters. The position peaked at $320K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Burns Matteson Capital Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Burns Matteson Capital Management sold 562 Medpace shares in Q2 2026, an estimated $270K.
  • Burns Matteson Capital Management first reported a position in Medpace in Q4 2025 and held it in 2 quarters.
  • Burns Matteson Capital Management's Medpace position peaked at $320K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.